Skip to main navigation Skip to search Skip to main content

Ipilimumab plus a galectin-3 inhibitor for metastatic melanoma

Project: Research

Project Details

StatusFinished
Effective start/end date01/1/16 → 01/1/18

Funding

  • NIH (NIH R21 CA190790-01)